What is noteworthy in our work is that the concomitant inhibition of TLK1 along with ADT results in the specific killing of androgen-sensitive (AS) PCa cells instead of the more generalized, and thus more prone to side effects, inhibition of ATR or ATM. The gene discussed is ATM; the disease is posterior cortical atrophy.